« Return to News | Technology Solutions

Datatrak Delisted from NASDAQ

Wednesday, June 10, 2009 07:30 AM

Datatrak, a Cleveland-based  eClinical company, was delisted from the stock exchange after failing to meet NASDAQ's $2.5-million minimum stockholders' equity requirement.

The company will trade its shares over the counter under the same symbol (DATA).  The delisting came as no surprise to Datatrak, which received a letter from NASDAQ last August warning the company that it was not in compliance with the stock exchange's minimum equity requirement. Datatrak had until June 1 to comply with NASDAQ's requirements.

Datatrak's struggles began more than a year ago as the company posted several quarters of losses and retained Healthcare Growth Partners as a strategic and financial advisor in an effort to increase the company's value. For the most recent quarter, Datatrak's loss was $787,000, a decrease from more than $2 million for the same period last year.

CEO Jeffrey Green stepped down in January, after 17 years, and the company has yet to replace him.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.